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EXPERIMENTAL PRODUCTION OF CIRCULATING ANTIBOI)T FS
TO CHROMIUM*
HAIM A. COHEN, M.D.
A positive potassium biehromate patch test
in eases of contact type eczema due to cement,
shoe leather, or other materials, suggests sensi-
tivity to chromium to be an underlying factor
(1—8). it is known that inorganic salts of metals
may act as allergens, but no circulating anti-
bodies to such inorganic compounds have yet
been detected. Some simple organic compounds,
however, when injected in the form of conjugated
antigens, are capable of stimulating circulating
antibody production in animals (9).
Keogh, North and Warburton (10) found
that an extract of hemophilus influenza can be
attached to red blood cells and renders them
specifically agglutinable by homologous bacterial
antibodies. They later reported similar findings
with several other polysaeebaride antigens of
bacterial origin (11). This type of reaction has
been referred to as indirect, passive, or condi-
tional hemagglutination (12). Boyden (13) ob-
served that washed sheep erythrocytes treated
with dilute solutions of tannie acid can absorb
protein, and that they are then agglutinable by
specific antisera to the attached protein. These
observations have since been confirmed and
extended (12). Landsteiner and van der Sheer
(14) linked diazo compounds to red blood cell
"ghosts". The complex became agglutinable by
specific antisera to azoproteins derived from
these compounds. Pressman, Campbell and
Pauling (15) showed that sheep erythroeytes to
which azophenylarsonate or ovalbumin had been
attached were agglutinable by the specific
antisera.
It therefore seems that erythroeytes, after
eensitization with polysaccbarides, proteins, or
simple organic compounds, can both induce
antibody production to the attached substance,
and react in vitro with specific antisera to at-
tached compounds, and produce hemagglutina-
* From the Department of Dermatology and
Venereology, Hadassah University Hospital,
Jerusalem, Israel.
This work was aided in part by grants from the
Frances Paseher Research Fund in Dermatology,
the Cantor Fund, and the Estate of Nellie Neuhau-
sen.
Received for publication April 1, 1901.
13
tion. This encouraged the speculation that
perhaps even a simple ion, if attached to the
surface of the red cell, might act in a similar
manner.
Before describing the experiments based on
this speculation, the phenomenon of the direct
agglutination of erythroeytes by metallic eations
merits consideration. Jandl and Simmons (16)
thought such agglutination to result from firm
attachment of the metallic cations (e.g. chro-
mium) to the red cell membranes. The conse-
quent reduction of the negative surface charge
might then permit erythroeyte aggregation.
They also thought it possible that the metallic
eations might form direct cross-linkages between
the red cells. The hemagglutination was found
to be inhibited by substances containing poly-
earboxylie groups, and by normal human or
animal serum. The serum may have acted either
by competing with the erythroeytes for the
binding of the available chromium, or by pro-
viding a protective coating around the chromium-
red cell complex.
in the experiments described in this paper,
the metallic ion was joined to the surface of
human erythroeytes, and the conjugated antigen
was then injected into rabbits in an attempt to
stimulate the production of antiserum containing
specific antibodies to chromium. It was thought
possible that such an antiserum, added to the
chromium-red cell complex in vitro, might
produce an agglutination phenomenon instead
of a protective one.
MATERIALS AND METHODS
Preparation of the antigens for immunization.
2.0 ml of packed group "0" human erythrocytes
were added to 0.2 ml—0.4 ml of a 0.5% potassium
bichromate solution (0.03 M sol) in 10 ml of normal
saline. After standing at room temperature for 15
minutes to allow the ions to become attached to
the erythroeyte surface, the red cells were thrice
washed with normal saline and re-suspended in
another 10 ml of normal saline, giving a 20% sus-
pension. A similar procedure was followed for the
preparation of chromium chloride-sensitized
erythrocytes.
Immunization of the rabbits. Rabbits of 2 kg.—3
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kg. weight were used, and were separated into
four groups.
Group I: Five rabbits were each given six
hi-weekly intravenous injections of 2.0 ml of
the potassium bichromate-sensitized erythro-
cyte suspension.
Group II: Seven rabbits were similarly treated
with the chromium chloride-sensitized erythro-
cytes.
Group III: Two rabbits were each given two
intramuscular injections, at 15 day intervals,
of 0.5 ml of Freund's adjuvants (17) containing
potassium bichromate.
Group IV: Two rabbits were similarly treated
with 0.5 ml of Freund's adjuvants containing
chrome chloride and crystalline bovine albumin.
Preparation of sensitized erythrocytes for in
vitro test. 0.2 ml of fresh, packed and washed
group "0" human erythrocytes from defibrinated
blood, were suspended in 10 ml of normal saline
containing 0.1 of the stock solution of 0.5% po-
tassium bichromate or chromium chloride. After
standing for 15 minutes at room temperature the
red cells were thrice washed in normal saline and
resuspended in another 10 ml normal saline. After
initial centrifugation at low speed for 2 minutes,
the red cells sensitized with chromium chloride
were found to be strongly agglutinated at the
bottom of the test tube. This did not occur at
all with the potassium bichromate-sensitizcd
cells. Gently shaking the agglutinate each time
in fresh normal saline broke the mass down to
small agglutinates of varying sizes. After the
third washing a fine suspension of very small
agglutinates was obtained.
Performance of the in vitro test. The antisera
were first inactivated at 56° C for 3 hr., and the
agglutinins against erythrocytes were removed by
repeated absorptions at room temperature with
untreated, packed, group "0" red cells. The
test procedure follows:
1. Prepare serial dilutions of 0.2 ml antisera
and of control sara, in 0.2 ml normal saline.
2. To each dilution add 0.1 ml of 2% sensitized
red cell suspension, and shake.
3. Allow the erythrocytes to sediment at room
temperature.
Controls. Sera taken from rabbits before im-
munization and sera from non-immunized rabbits
were similarly treated and used as control sara.
In addition, the antisera were also tested with
non-sensitized erythrocytes.
Reading of the results. The results were read
several times from 2 to 24 hours after the per-
formance of the test. The form of sedimentation
of the red cells as seen through the bottom of
the test tube was evaluated according to the
criteria of Salk (18). A negative result was
evidenced by a sediment in the form of a small)
compact, hutton-like mass. A positive result,
representing passive hemagglutination, con-
sisted of sedimentation spread over a much
wider area. Blurring or raggedness of the edges
of this area indicated a high antibody titer in
the serum.
EESULTS
Three rabbits died during the period of im-
munization, two from Group I and one from
Group II. The remaining rabbits died from un-
ascertained causes within 3 weeks of the end of
immunization.
The sera of the Group I rabbits, which were
immunized with potassium bichromate-sensitized
red cells, did not contain antibodies against
potassium biehromate-scnsitized erythrocytes,
but contained antibodies against chromium
chloride-sensitized erythrocytes (Fig. 1).
The sera of the Group II rabbits contained
antibodies against chromium chloride-sensitized
erythroeytes (Fig. 1).
The sera of Group III and Group IV rabbits
did not contain antibodies against either potas-
sium bichromate- or chromium chloride-sensi-
tized crythroeytes.
INVESTIGATION OF SPECIFICITy
The following experiments were performed to
determine the specificity of the antibodies to
chromium.
Experiment I: Substitution of Sheep for
human Erythrocytes
To determine whether the specificity of the
antibodies was independent of the particular
red cell used, experiments using sensitized sheep
erythrocytes were performed. The inactivated
rabbit antisera used were first treated with
packed, normal sheep erythroeytes to eliminate
heterophil antibodies against sheep red cells.
The cells tested were sensitized by the same
procedure as that used for the human cells. All
the sera tested gave positiee results, suggesting
that the reaction was not dependent upon the
erythrocyte used.
Experiment II: Substitution of Erythrocytes
Sensitized with Other Metals
To determine whether the antibodies were
specific only to chromium, the test was repeated
with human group "0" erythroeytes sensitized
with FeC13, A1C13, NiC12, and CoC12. Because
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FIG. 1. Reactions of rabbits injected with either potassium chromate sensitized erythrocytes or
chromium chloride sensitized erythrocytes tested against chromium chloride sensitized erythrocytes.
Rows A—E represent individual immunized rabbits. Row F is a normal rabbit prior to immunization.
Columns 1—5 represent progressive serial dilutions of the immune sera (dilutions 1:4 to 1:64). Column
6 represents undiluted immune sera tested against normal (non-sensitized) erythroeytes.
In all except the control tubes there is hemagglutination, indicating the presence of antibodies to
chromium chloride. (The blank spaces represent tubes removed because of hemolysis.)
Rabbit A
Rabbit B
Rabbit C
Rabbit D
Rabbit E
Rabbit F
ferric chloride and aluminum chloride themselves
strongly agglutinate red cells, sensitization with
these salts was done with dilutions of 0.01 ml
and 0.025 ml respectively, of a 0.5% stock solu-
tion, per 0.2 ml packed erythroeytes. A parallel
control was carried out, using red cells sensitized
with chromium chloride in a dilution of 0.025 ml
of an 0.5% stock solution of 0.2 ml packed red
cells. All the reactions were negatice with the ex-
ception of the control and that in which ferric
chloride-sensitized red cells were used.
Experiment III: Precious Absorption of
Antibodies to Chromium by Packed
Sensitized Erythrocytcs
Antisera from Group I and Group II rabbits
were inactivated and absorbed with normal group
"0" human erythrocytes. The sera were then
tested in a dilution of 1:2, against the suspension
of chromium chloride-sensitized erythrocytes.
The test was then repeated with the same sera
after they had undergone one to three successive
absorptions with packed, sensitized to chromium
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Fio. 2. Serum of rabbits injected with potassium bichromate (top row) or chromium-chloride (bottom
row) sensitized erythrocytes. The first tubes represent control serum, taken before the injection, with
normal human erythrocytes. The remaining tubes show the weakening of passive hemagglutination
reaction following successive absorptions with packed chromium-chloride-sensitized erytbrocytes.
A
B
C
D
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FIG. 3. Demonstration of inhibition reactioo. See text for interpretation of results
chloride erytbrocytes. The results (Fig. 2) seemed
to indicate that antibodies to chromium had been
absorbed by the packed, sensitized erythrocytes,
and that the previously positive sera had become
negative.
Experiment IV: Demonstration of
Inhibition Reaction
If an antigen is added to homologous antiserum
before the sensitized erythrocytes are introduced,
specific antibodies should combine with the
antigen and the positivity of the hemagglutina-
tion reaction 'nay be diminished or abolished.
When metallic cations are used as antigens some
complicating factors are introduced. These are
discussed later.
(a) 0.1 ml of a 2% suspension of chromium
chloride-sensitized sheep erythrocytes was added
to each of five tubes containing 0.2 ml of anti-
serum in dilutions of —)'fiz (Fig. 3, row A)
0 0
0 O 0 o 0
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and to five tubes containing 0.2 ml of normal
rabbit serum in similar dilutions (Fig. 3, row
B). Heterophil antibodies had been removed
from the sera by previous absorptions. After
standing at room temperature for 10 minutes,
0.2 ml of a h000 dilution of the 0.5% stock
solution of chromium chloride was added to
each tube. All of the five tubes containing anti-
serum showed a definite positive hcmagglutina-
tion, indicating that the subsequently added
chromium chloride was unable to inhibit the
hcmagglutination reaction. Of the five tubes
containing normal rabbit serum, the first two
tubes showed no hemagglutination. A slight
hemagglutination occurred in the third tube and
a definitely positive hemagglutination in the
fourth and fifth tubes.
(b) The experiment was repeated using the
same materials and quantities, but in this case
the chromium chloride was added 10 minutes
before introducing the sensitized red cells. In
the tubes containing antiserum (Fig. 3, row C)
inhibition of the reaction occurred in the first
tube, whilst in the remaining four tubes there
was positive agglutination. Of the tubes con-
taining normal serum (Fig. 3, row B), the first
three showed 110 hcmagglutination, but there
was a positive hemagglutination in the fourth
and fifth tubes.
A possible interpretation of some unexpected
results in these inhibition experiments is given
in the discussion.
DISCUSSION
The passive hemagglutination reaction, which
utilizes erythrocytcs as carriers of antigenic
material, has frequently been used in the search
for specific circulating antibodies to polysac-
charides and proteins (19—26). The antigen in
the present experiments was a metallic cation;
it attaches to the crythrocyte directly as when a
polysaccharide antigen is used. Metallic cations
are capable of producing smaller or greater
degrees of direct hemagglutination, varying
with the concentration of the metallic ions.
Jandi and Simmons (16) suggested that metallic
cations are bound to the erythrocytc surface by
COOH groups. The inhibition of this direct ag-
glutination by certain organic materials was
apparently due to the fact that the latter also
possessed this carboxyl grouping. The most
strongly negatively charged serum constituents
will most strongly attract the metallic cations,
union being most rapid with albumin, followed
in descending order by a, j3, and -y globulins
and fibrinogen. The fine agglutinates present in
these tests, in which low concentrations of
metallic cations were used, did not interfere
with the phenomenon of passive hcmagglutina-
tion occurring after the addition of antibody.
The results of the experiments reported in this
paper suggested that the sera of the immunized
rabbits contained specific antibodies to trivalent
chromium. Thus, the passive hemagglutination
test was positive with chromium chloride-sensi-
tized sheep, as well as human erythrocytes, and
was negative in most cases in which other metals
were substituted for the chromium. The excep-
tion in the case of iron might have been due to
the production of antibodies to this metal during
the immunization process, in which there was
a liberation of hemoglobin from the sensitized
human erythrocytes injected into the rabbits.
Further evidence for the presence of specific
antibodies was the progressive weakening and
final abolition of the hemagglutination reaction
following treatment of the antiserum with
packed chromium chloride-sensitized red cells.
Interpretation of the inhibition reaction ex-
periments was somewhat less simple. It must
be noted that metallic cations were used as
antigen. Polysaccharide or protein antigens will
only attach themselves specifically to antibodies,
but metallic cations may, in addition, become
non-specifically attached to any or all of the
protein fractions of the serum. In experiments
4(a) and 4(b) the hemagglutination which
occurred in the tubes containing the two or
three highest dilutions of normal rabbit serum
(Fig. 3, rows B and D) was unexpected. It is
possible that the excess of chromium eations,
resulting from the higher dilution of the serum,
was in some way capable of forming complexes
between the normal serum proteins and the
sensitized erythrocytes, producing a non-specific
hemagglutination. The hemagglutination which
occurred in all except the lowest of the dilutions
of antiserum to which chromium chloride had
been added prior to adding erythroeytes (Fig.
3, row C), could be due to the same mechanism.
However, a comparison of the second arid third
dilutions in this series with the equivalent dilu-
tions in the control, normal serum (which showed
no hemagglutination) indicates that at these
18 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
dilutions there may be a greater affinity between
the immune serum proteins, the excess of metallic
eations, and the sensitized red cells than exists
in the case of normal serum. (Fig. 3, rows C and
D, tubes 2, 3).
The fact that the sera of the rabbits given
injections of potassium bichromate-sensitized
erythrocytes did not contain antibodies to po-
tassium bichromate (hexavalent chromium) but
only to chromium chloride (trivalent chromium),
is of interest from both experimental and clinical
viewpoints. By contrast, in patients with chro-
mium dermatitis the patch test to potassium
bichromate is positive and that to chromium
chloride negative. An explanation of this ap-
parent paradox may lie in the fact that poly-
saccharides are known to be capable of reducing
the hexavalent chromium of chromate salts to
trivalent chromium. The skin, with the exception
of the stratum corneum, is rich in polysaccharides,
which may thus act as reducing agents for
chromates penetrating into or through the ground
substance. Penetration of chromium through
the skin was studied in 6 normal and in 6 chro-
mium-sensitive individuals (27). Within 24
hours of the application of radioactive chromate
to the skin, radioactivity was detected in erythro-
cytes, plasma and urine. There was no quan-
titative difference between the two groups
tested. Individuals suffering from contact
dermatitis due to chromium have probably
absorbed large amounts of this substance, mainly
through their skin, over considerable periods of
time. The chromium may have entered the cir-
culation either as a chromate or as a trivalent
chromium salt after reduction by polysaceharides
of the ground substance. Even in the former
case, however, it seems probable that the chro-
mate would be finally reduced to trivalent form.
Parallel phenomena have been observed with
azodyes and other chemical substances, both in
animals and in sensitized individuals (28—33).
Assuming that reduction of chromate to
trivalent chromium does take place in the skin
of humans, the results of the patch tests to
potassium bichromate and to chromium chloride
in chromium-sensitive patients might be explain-
able as follows: The externally applied ebromate
penetrates the stratum corneum, without form-
ing any complexes with the negatively charged
proteins or other substances present in this
layer. At a deeper layer it undergoes reduction.
The resultant trivalent chromium reacts or
combines with the polysaeeharides of the ground
substance, or with protein of a different nature
from those present in the stratum eorneum. To
this complex antibodies are formed. Externally
applied trivalent chromium, by contrast, readily
combines with the negatively charged albu-
minoid-type proteins in the stratum corneum.
To such a complex the individual suffering from
"ehromate" dermatitis has formed no anti-
bodies, and the chromium chloride patch test
result is therefore negative.
The experiments here described may com-
plimnent those of Frei (34), Sulzberger (35), and
Haxthausen (36—37), who induced hypersensi-
tivity to metals in animals and in human. The
last author gave intradermal injections of
mercury, chromie acid, or formalin, mixed with
horse serum, to individuals previously demon-
strating negative results to patch tests with
these substances. In each ease sensitivity to the
substance injected was produced. Attempts to
demonstrate the presence of reagins by the
Prausnitz-ICustner test were unsuccessful. Land-
steiner and Chase (38) induced skin sensitivity
in guinea-pigs by the intraperitoneal injection
of simple chemical compounds and homologous
red cell ghosts.
Under certain experimental conditions in
guinea-pigs circulating antibodies to chemical
compounds has been produced, depending upon
the nature and amount of the antigen injected
(39—42). The present work indicates that a some-
what similar phenomenon can be demonstrated
in rabbits.
5UMMAaY
It was demonstrated, by means of the passive
hemagglutination reaction, that the sera of
rabbits given intravenous injections of human
Group "0" erythroeytes sensitized with either
potassium biehromate or chromium chloride
contained antibodies only to the trivalent
chromium. The sera of rabbits injected with the
same chromium salts plus Freund adjuvants and
Crystalline bovine albumin did not contain
antibodies to chromium.
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